Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer

Background: Previous prospective studies have shown that eribulin improves the survival in patients with metastatic breast cancer (MBC). However, the optimal timing of its administration to achieve the longest extended survival and the efficacy of using eribulin monotherapy as earlier-line chemother...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Cancer
Huvudupphovsmän: Shingaki, Sumito, Kogawa, Takahiro, Shimokawa, Mototsugu, Harano, Kenichi, Naito, Yoichi, Kusuhara, Shota, Fujimoto, Yumi, Matsubara, Nobuaki, Hosono, Ako, Mukai, Hirofumi, Onishi, Tatsuya, Hojo, Takashi, Mukohara, Toru
Materialtyp: Artigo
Språk:Inglês
Publicerad: Ivyspring International Publisher 2020
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7196254/
https://ncbi.nlm.nih.gov/pubmed/32368292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.37670
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk